Alpa Laboratories Limited
NSE:ALPA.NS
111.64 (INR) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,087.39 | 924.362 | 1,105.133 | 964.135 | 848.704 | 764.219 | 613.193 | 656.812 | 535.9 | 573.939 | 567.083 | 561.085 | 551.299 | 819.543 | 934.367 | 1,216.848 |
Cost of Revenue
| 898.495 | 631.76 | 760.872 | 647.555 | 552.752 | 530.896 | 398.332 | 418.546 | 307.192 | 400.104 | 366.458 | 403.193 | 431.241 | 728.835 | 844.953 | 1,127.102 |
Gross Profit
| 188.895 | 292.602 | 344.261 | 316.58 | 295.952 | 233.323 | 214.861 | 238.266 | 228.708 | 173.835 | 200.625 | 157.892 | 120.057 | 90.708 | 89.414 | 89.746 |
Gross Profit Ratio
| 0.174 | 0.317 | 0.312 | 0.328 | 0.349 | 0.305 | 0.35 | 0.363 | 0.427 | 0.303 | 0.354 | 0.281 | 0.218 | 0.111 | 0.096 | 0.074 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 10.771 | 17.231 | 22.032 | 20.779 | 18.819 | 10.186 | 13.401 | 76.545 | 85.223 | 6.187 | 6.051 | 0 | 45.317 | 46.608 | 42.645 |
Selling & Marketing Expenses
| 0 | 51.607 | 57.926 | 44.875 | 53.425 | 50.036 | 41.179 | 9.092 | 2.915 | 2.852 | 28.496 | 19.197 | 0 | 0 | 0 | 0 |
SG&A
| 127.38 | 62.378 | 75.157 | 66.907 | 74.204 | 68.855 | 51.365 | 22.493 | 79.46 | 88.075 | 134.669 | 105.017 | 0 | 45.317 | 46.608 | 42.645 |
Other Expenses
| 148.897 | 99.327 | 1.483 | 0.516 | 1.062 | 0.467 | 0.071 | 1.793 | 0.747 | 1.083 | 0.15 | 0.234 | 0.005 | 18.159 | 31.387 | 36.096 |
Operating Expenses
| 127.38 | 230.296 | 248.849 | 219.415 | 250.805 | 237.844 | 194.493 | 202.851 | 145.517 | 200.23 | 234.457 | 173.769 | 104.388 | 63.476 | 77.995 | 78.741 |
Operating Income
| 61.515 | 67.616 | 90.058 | 74.046 | 47.119 | 2.401 | 184.549 | 35.415 | 83.191 | -26.395 | -33.832 | -15.877 | 15.67 | 27.231 | 11.419 | 11.005 |
Operating Income Ratio
| 0.057 | 0.073 | 0.081 | 0.077 | 0.056 | 0.003 | 0.301 | 0.054 | 0.155 | -0.046 | -0.06 | -0.028 | 0.028 | 0.033 | 0.012 | 0.009 |
Total Other Income Expenses Net
| 145.305 | 91.287 | 105.561 | 33.819 | -18.044 | 25.162 | -138.349 | 3.193 | 14.183 | -0.722 | -15.681 | -16.249 | -7.314 | -16.413 | -1.274 | 0.494 |
Income Before Tax
| 206.82 | 159.399 | 195.62 | 107.864 | 29.075 | 25.385 | 46.2 | 38.608 | 97.374 | -27.117 | -49.513 | -32.126 | 8.355 | 10.819 | 10.145 | 11.499 |
Income Before Tax Ratio
| 0.19 | 0.172 | 0.177 | 0.112 | 0.034 | 0.033 | 0.075 | 0.059 | 0.182 | -0.047 | -0.087 | -0.057 | 0.015 | 0.013 | 0.011 | 0.009 |
Income Tax Expense
| 39.055 | 33.075 | 54.702 | 35.394 | 10.541 | 17.446 | 18.4 | 29.301 | 28.914 | -13.141 | 2.036 | 11.554 | 3.071 | 1.78 | 2.18 | 7.713 |
Net Income
| 167.765 | 126.324 | 140.917 | 72.471 | 18.534 | 7.939 | 27.9 | 9.308 | 68.461 | -13.977 | -51.548 | -43.68 | 5.285 | 9.039 | 7.965 | 3.786 |
Net Income Ratio
| 0.154 | 0.137 | 0.128 | 0.075 | 0.022 | 0.01 | 0.045 | 0.014 | 0.128 | -0.024 | -0.091 | -0.078 | 0.01 | 0.011 | 0.009 | 0.003 |
EPS
| 8.01 | 5.98 | 6.7 | 3.44 | 0.88 | 0.35 | 1.33 | 1.2 | 3.25 | -0.66 | -2.45 | -2.08 | 0.25 | 0.43 | 0.38 | 0.18 |
EPS Diluted
| 8.01 | 5.98 | 6.7 | 3.44 | 0.88 | 0.35 | 1.33 | 1.2 | 3.25 | -0.66 | -2.45 | -2.08 | 0.25 | 0.43 | 0.38 | 0.18 |
EBITDA
| 81.064 | 174.917 | 130.15 | 112.489 | 102.855 | 70.571 | 95.83 | 116.319 | 141.624 | 60.036 | 56.76 | 31.408 | 25.701 | 42.162 | 20.958 | 25.466 |
EBITDA Ratio
| 0.075 | 0.189 | 0.118 | 0.117 | 0.121 | 0.092 | 0.156 | 0.177 | 0.264 | 0.105 | 0.1 | 0.056 | 0.047 | 0.051 | 0.022 | 0.021 |